In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...
The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on social ...
News-Medical.Net on MSN
Taking anticoagulants alongside prostate cancer drugs does not increase bleeding risk
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer​.
The results of the clinical trial mark a setback for the Swiss pharmaceutical company, which saw in the drug, giredestrant, a candidate to become a blockbuster treatment.
New research suggests childhood cancer survivors may experience accelerated biological aging from treatments, potentially ...
As a world leader in the immuno-oncology field, Dr. Zihai Li has long been at the forefront of cancer immunotherapy.
A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.
Meagan Meadows was diagnosed with stage 3 colon cancer at just 24, but she rang the bell after her last round of chemo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results